Zentrela

Zentrela is a pioneering neurotechnology company based in Hamilton, Ontario, specializing in the objective quantification of cannabis product effects on consumer mental states. The company operates in the rapidly growing cannabis industry, addressing a critical information gap for consumers who seek reliable data on the psychoactive effects of various cannabis products. Zentrela's core product is a scientifically proven platform that uses advanced brainwave (EEG) research and artificial intelligence to analyze the cognitive impact of cannabis. This technology empowers consumers to make informed purchase and consumption decisions, thereby fostering trust and transparency in the cannabis market.

Zentrela primarily serves cannabis producers, retailers, and consumers. The business model revolves around providing data-driven insights that validate product formulations and help build trusted consumer brands. Revenue is generated through partnerships with cannabis companies that utilize Zentrela's platform to enhance their product offerings and marketing strategies.

The company recently secured $850,000 in seed funding, which will be used to further develop its neurotechnology platform and expand its database of cannabis psychoactive effects. Led by a team of Canadian scientists from the fields of neuroscience and artificial intelligence, Zentrela aims to become the standard for quantifying product effects in the cannabis industry.

Keywords: neurotechnology, cannabis, EEG, AI, cognitive impairment, product validation, consumer insights, brainwave research, psychoactive effects, data-driven.